Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-063688
Filing Date
2025-06-27
Accepted
2025-06-27 17:07:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2519005d1_424b5.htm 424B5 7585
2 GRAPHIC tm2519005d1_424b5img001.jpg GRAPHIC 6080
  Complete submission text file 0001104659-25-063688.txt   17143
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282458 | Film No.: 251087666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)